Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

NOD2 regulates hematopoietic cell function during graft-versus-host disease.

Penack O, Smith OM, Cunningham-Bussel A, Liu X, Rao U, Yim N, Na IK, Holland AM, Ghosh A, Lu SX, Jenq RR, Liu C, Murphy GF, Brandl K, van den Brink MR.

J Exp Med. 2009 Sep 28;206(10):2101-10. doi: 10.1084/jem.20090623. Epub 2009 Sep 8.

2.

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.

Lu SX, Kappel LW, Charbonneau-Allard AM, Atallah R, Holland AM, Turbide C, Hubbard VM, Rotolo JA, Smith M, Suh D, King C, Rao UK, Yim N, Bautista JL, Jenq RR, Penack O, Na IK, Liu C, Murphy G, Alpdogan O, Blumberg RS, Macian F, Holmes KV, Beauchemin N, van den Brink MR.

PLoS One. 2011;6(7):e21611. doi: 10.1371/journal.pone.0021611. Epub 2011 Jul 6.

3.

NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.

Jaskula E, Lange A, Kyrcz-Krzemien S, Markiewicz M, Dzierzak-Mietla M, Jedrzejczak WW, Czajka P, Mordak-Domagala M, Lange J, Gronkowska A, Nowak J, Warzocha K, Hellmann A, Kowalczyk J, Drabko K, Gozdzik J, Mizia S; Polish Donor-Recipient Matching Group.

Biol Blood Marrow Transplant. 2014 Mar;20(3):409-14. doi: 10.1016/j.bbmt.2013.12.558. Epub 2013 Dec 15.

4.

Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation.

Toubai T, Guoqing H, Rossi C, Mathewson N, Oravecz-Wilson K, Cummings E, Wu J, Sun Y, Choi S, Reddy P.

Oncoimmunology. 2015 Apr 1;4(7):e1016699. eCollection 2015 Jul.

5.

Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease.

Landfried K, Bataille F, Rogler G, Brenmoehl J, Kosovac K, Wolff D, Hilgendorf I, Hahn J, Edinger M, Hoffmann P, Obermeier F, Schoelmerich J, Andreesen R, Holler E.

Clin Exp Immunol. 2010 Jan;159(1):87-92. doi: 10.1111/j.1365-2249.2009.04049.x. Epub 2009 Nov 11.

6.

Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.

Ordemann R, Hutchinson R, Friedman J, Burakoff SJ, Reddy P, Duffner U, Braun TM, Liu C, Teshima T, Ferrara JL.

J Clin Invest. 2002 May;109(9):1249-56.

7.

Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.

Tanabe T, Yamaguchi N, Matsuda K, Yamazaki K, Takahashi S, Tojo A, Onizuka M, Eishi Y, Akiyama H, Ishikawa J, Mori T, Hara M, Koike K, Kawa K, Kawase T, Morishima Y, Amano H, Kobayashi-Miura M, Kakamu T, Nakamura Y, Asano S, Fujita Y.

Int J Hematol. 2011 Jun;93(6):771-8. doi: 10.1007/s12185-011-0860-5. Epub 2011 May 15.

PMID:
21573891
8.

Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.

Silva IA, Olkiewicz K, Askew D, Fisher JM, Chaudhary MN, Vannella KM, Deurloo DT, Choi SW, Pierce EM, Clouthier SG, Liu C, Cooke KR.

Biol Blood Marrow Transplant. 2010 May;16(5):598-611. doi: 10.1016/j.bbmt.2009.12.007. Epub 2010 Feb 1.

9.

Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease.

Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL, Lineburg KE, Cheong M, Robb RJ, Markey KA, Varelias A, Malissen B, Hämmerling GJ, Clouston AD, Engwerda CR, Bhat P, MacDonald KP, Hill GR.

Nat Med. 2011 Nov 29;18(1):135-42. doi: 10.1038/nm.2597.

PMID:
22127134
11.
13.

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.

Zhang Y, Shlomchik WD, Joe G, Louboutin JP, Zhu J, Rivera A, Giannola D, Emerson SG.

J Immunol. 2002 Dec 15;169(12):7111-8.

14.

Cellular and cytokine effectors of acute graft versus host disease.

Ferrara JL.

Int J Hematol. 2002 Aug;76 Suppl 1:195-8.

PMID:
12430853
15.

Recipient B cells are not required for graft-versus-host disease induction.

Matte-Martone C, Wang X, Anderson B, Jain D, Demetris AJ, McNiff J, Shlomchik MJ, Shlomchik WD.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1222-30. doi: 10.1016/j.bbmt.2010.03.015. Epub 2010 Mar 23.

16.

A crucial role for host APCs in the induction of donor CD4+CD25+ regulatory T cell-mediated suppression of experimental graft-versus-host disease.

Tawara I, Shlomchik WD, Jones A, Zou W, Nieves E, Liu C, Toubai T, Duran-Struuck R, Sun Y, Clouthier SG, Evers R, Lowler KP, Levy RB, Reddy P.

J Immunol. 2010 Oct 1;185(7):3866-72. doi: 10.4049/jimmunol.1001625. Epub 2010 Sep 1.

17.

Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.

Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R, Ottinger H, Rath PM, Ross RS, Roggendorf M, Grosse-Wilde H, Beelen DW.

Transplantation. 2006 Jan 27;81(2):247-54.

PMID:
16436969
18.

Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.

Kim HS, Shin TH, Lee BC, Yu KR, Seo Y, Lee S, Seo MS, Hong IS, Choi SW, Seo KW, Núñez G, Park JH, Kang KS.

Gastroenterology. 2013 Dec;145(6):1392-403.e1-8. doi: 10.1053/j.gastro.2013.08.033. Epub 2013 Aug 21.

PMID:
23973922
19.

Nucleotide-binding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice.

Jamontt J, Petit S, Clark N, Parkinson SJ, Smith P.

J Immunol. 2013 Mar 15;190(6):2948-58. doi: 10.4049/jimmunol.1201332. Epub 2013 Feb 8.

20.
Items per page

Supplemental Content

Write to the Help Desk